Clinical Trial Results: Positive trial outcomes generally boost investor confidence, leading to price increases. Negative results often cause price declines.

Regulatory Approvals: Approval of a drug by regulatory bodies like the FDA (or equivalent in Israel) can significantly raise the stock price. Delay or rejection can negatively affect it.

Partnerships and Collaborations: Agreements with larger pharmaceutical companies can provide financial support and validation, increasing stock value. Lack of partnerships can hinder growth.

Financial Performance: Revenue, profitability, and cash flow influence investor perception. Strong financials often lead to higher stock prices; weak financials, to lower prices.

Market Sentiment: Overall market conditions and investor risk appetite play a role. Bull markets tend to lift all stocks, while bear markets depress them.

Competition: The emergence of competing drugs or therapies can negatively affect the potential market share and, therefore, the stock price.

News and Announcements: Major news events, like new drug applications, can cause significant price fluctuations.

Analyst Ratings: Recommendations from financial analysts can influence investor decisions and impact stock prices.